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osting by EAbstract Salivary gland neoplasms comprise phenotypically and biologically diverse lesions of
uncertain histogenesis.
Objectives: The present study was carried out to assess the immunohistochemical expression of
HER-2/neu protein and of silver binding nucleolar organizer regions in normal salivary tissue.
Materials and methods: Twenty parafﬁn blocks of salivary tumors containing surrounding normal
salivary tissue were used in the study. One section was processed to investigate HER-2/neu protein
expression and another section was stained to assess the mean Ag NOR counts in normal salivary
tissue.
Results: Only two cases of the studied normal salivary tissue showed HER-2/neu expression (10%),
which was expressed only in ductal cells with 4.2 ± 2.1 mean number of reactive cells per ﬁve high
power ﬁelds (HPFs). Statistically signiﬁcant (P= 0.01) higher mean Ag NOR counts in ductal
(2 ± 0.83) than in acinar cells (1.2 ± 0.01) of normal salivary tissue were found.
Conclusion: It was concluded from the data of the present study that ductal cells of normal salivary
tissue are a proliferative pool and an oncogenic target which plays an important role in the histo-
genesis of salivary gland tumors.
ª 2010 King Saud University. All rights reserved.om
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lsevier1. Introduction
Two main theories exist regarding the histogenesis and devel-
opment of salivary gland neoplasms. The ﬁrst one is the mul-
ticellular theory in which neoplasms arise from different
mature cells that have counterparts within the salivary gland
unit. For example, oncocytic tumors are believed to arise from
striated duct cells, acinus cell tumors from acinar cells and
mixed tumors from intercalated duct cells and myoepithelial
cells (Ellis and Auclair, 1996).
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states that basal cells of the excretory and intercalated ducts
serve as stem cells or reserve cells for the differentiation of
salivary gland units, and that salivary neoplasms arise from
either one of these reserve cells. Therefore, Warthin’s tumor,
oncocytic tumors, adenoid cystic carcinoma and acinus tumors
are thought to arise from intercalated duct reserve cells and
mucoepidermoid carcinoma and other more malignant neo-
plasms are thought to arise from the excretory duct reserve
cells (Ellis and Auclair, 1996; Eisele and Johns, 1988).
In addition to the previously mentioned theories, Redman
(1995) proposed that acinar cells is the primary candidate as
the stem cell of rat parotid gland which can differentiate into
other epithelial cells including ducts. A fourth theory of sali-
vary gland tumors histogenesis is that the intercalated duct re-
serve cells are thought to represent one aspect of the potential
bidirectional differentiation to ducts and acini (Eversole,
1971). Finally, other investigators suggested a role of myoepi-
thelial cells in the histogenesis of some salivary gland tumors
(Hubner et al., 1971).
HER-2/neu is a cell membrane surface bound receptor tyro-
sine kinase and is normally involved in the signal transduction
pathways leading to cell growth and differentiation. Salivary
gland carcinomas were found to show an ampliﬁcation of
the HER-2/neu gene or overexpression of it’s protein product
which was associated with increased disease recurrence and
worse prognosis (Batsakis et al., 1989; Glisson et al., 2004;
Giorgio et al., 2007).
Among the methods of evaluation of the proliferative activ-
ity is the argyrophilic nucleolar organizer region (Ag NOR)
technique, which uses silver to stain the proteins associated
with the active nucleolar organizer regions (NORs). NORs,
which transcribe ribosomal RNA (rRNA), are DNA segments
found on the short arms of acrocentric chromosomes 13, 14,
15, 21 and 22 of the human species. Active NORs are associ-
ated with non-histone and argyrophilic proteins, which are
known as Ag NORs when stained with silver. Number and size
of Ag NORs change according to the rhythm of ribosomal
RNA transcription (Schliephake, 2003).
The present study was carried out to assess the proliferative
activity of the cells in perilesional normal salivary tissue by
detecting their expression of silver binding nucleolar organizer
regions (Ag NORs) and HER-2/neu proteins.2. Materials and methods
The present study was carried out on 20 archival parafﬁn
blocks of salivary tumors obtained from Cairo National Can-
cer Institute and from Pathology Department of Mansoura
Faculty of Medicine in Egypt. These parafﬁn blocks were se-
lected after the evaluation of hematoxylin and eosin stained
sections by microscopical examination to assess the presence
of normal salivary tissue around tumors. The selected normal
salivary tissue sample fulﬁlled the following criteria; (a) not in-
vaded by tumor tissue; (b) not included within the tumor tis-
sue; (c) free of inﬂammatory, dysplastic or other abnormal
changes and ﬁnally; (d) of reasonable quantity for histopathol-
ogical and immunohistochemical studies.
From each parafﬁn block, two sections each of ﬁve microns
thickness were cut, the ﬁrst section was processed to evaluate
the immunohistochemical expression of HER-2/neu oncopro-tein in normal salivary tissue. The parafﬁn section was depara-
ﬁnised, rehydrated in graded alcohols, then treated with
blocking reagent for 5 min, washed in phosphate buffer work-
ing solution (PBS) for 5 min, after which one drop of monoclo-
nal mouse antibody to HER-2/neu (Dako, Denmark) was then
placed on the section (1:80 dilution). Negative controls were
obtained by omitting primary antibody replacing it with two
to three drops of non-speciﬁc serum.
Then slides were incubated overnight in a humidity cham-
ber, two to three drops of streptavidin enzyme were placed
on each slide, then several drops of the working color reagent
(DAB) were placed on each slide, slides were counterstained
with Myer’s hematoxylin, dehydrated and covers were
mounted using Canada balsam.
For each of the stained slides mean number of reactive cells
to anti-HER-2/neu per ﬁve high power ﬁelds (HPFs) was
calculated.
To assess the proteins associated with nucleolar organizer
regions (NORs), the second section from each parafﬁn block
was processed according to the method of Ploton et al.
(1986). Sections were dewaxed in xylene (3–5 min) and then
rehydrated through ethanols to distilled water. The Ag NOR
staining solution was prepared by dissolving the gelatin in
1% aqueous formic acid at a concentration of 2%. This solu-
tion was then mixed 1:2 volumes, with 50% aqueous silver ni-
trate solution, to give the ﬁnal working solution. This solution
was immediately poured over the tissue sections, and left for
60 min at room temperature. The silver solution was then
washed-off with distilled water and the sections were dehy-
drated through graded ethanols to xylene and covers were
mounted with Canada balsam.
All the stained slides were examined using X100 oil immer-
sion objective lens at a total magniﬁcation of X1000. Ag NOR
dots were counted, the mean number of Ag NOR dots from
ﬁve HPFs in each slide was determined for each type of cells
with Ag NORs expression separately (Schliephake, 2003). Ag
NOR dots that could not be distinguished from each other
were counted as a single dot, following the standardized ap-
proach described by Crocker et al. (1989).
Statistical analysis was carried out with SPSS 10 software
for data analysis and processing.3. Results
3.1. Immunohistochemical ﬁndings (Table 1)
Only ductal cells were reactive to anti-HER-2/neu protein. The
HER-2/neu positive cells revealed yellowish to brown faint
cytoplasmic staining which appeared membranous in some
cells lying directly adjacent to the cell membrane (Fig. 1) and
in other cells, showed a patchy cytoplasmic distribution
(Fig. 2). The HER-2/neu positive cells were evident in two
(10%) out of the studied 20 normal salivary tissue cases. The
mean number of reactive cells per ﬁve HPFs was 4.2 ± 2.1.
3.2. Ag NORs ﬁndings (Table 2)
Ag NORs were evident as black dots in the cell nucleoli which
was expressed in both acinar and ductal cells of all the studied
salivary tissue cases. In acinar cells, usually one to two large
Ag NOR dots were seen (Fig. 3), meanwhile, ductal cells re-
Figure 4 Multiple Ag NOR dots in ductal cells nucleoli of
normal salivary tissue (Ag NOR, original magniﬁcation ·1000).
Figure 2 Cytoplasmic expression of HER-2/neu protein in
ductal cells of normal salivary tissue (anti-HER-2/neu, original
magniﬁcation ·400).
Figure 3 One or two (arrow) Ag NOR dots in acinar cells of
normal salivary tissue (Ag NOR, original magniﬁcation ·1000).
Table 1 HER-2/neu expression in the studied normal salivary
tissue.
Number of positive cases 2/20
Percentage of positive cases 10%
Mean number of positive cells/ﬁve HPFs ± SD 4.2 ± 2.1
SD= standard deviation.
Figure 1 HER-2/neu expression in ductal cells of normal
salivary tissue, note the completely negative acini and in the inset,
the membranous pattern of expression (anti-HER-2/neu, original
magniﬁcation ·40).
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in acinar cells (Fig. 4). The total mean Ag NOR count for both
ductal and acinar cells per ﬁve HPFs of the studied normal sal-
ivary tissue cases was 1.6 ± 0.5. The mean Ag NOR counts in
ductal cells of normal salivary tissue was 2 ± 0.83 dots/5HPFs
(Table 2) which was found to be statistically signiﬁcantly high-
er than that of the acinar cells (1.2 ± 0.01, P= 0.01).4. Discussion
Salivary gland neoplasms comprise phenotypically and biolog-
ically diverse lesions of uncertain histogenesis. The molecular
events associated with their development and clinicopatholog-
ical heterogeneity are yet not fully understood (Maruya et al.,
2004).
The ﬁndings of the present work of 10% expression of
HER-2/neu protein among normal salivary gland tissue were
similar to those in the study of Negri et al. (2008), as they re-
ported 25% expression (two cases of eight) of HER-2/neu pro-
tein in normal salivary tissue. The higher value of HER-2/neu
expression in the later study may be due to the difference of the
method used, as they used in situ hybridization method for
HER-2/nue protein detection which may be more sensitive
than the immunohistochemical method used in the present
study. Similarly, Quirke and coworkers (Quirke et al., 1989)
detected HER-2/neu in a wide variety of epithelial and non-
epithelial tissues of human fetus. Moreover, HER-2/neu was
expressed in epithelial cells of normal breast, it was proposed
Table 2 Mean number of Ag NORs in ductal and acinar cells
of the studied salivary gland cases.
Ductal cells Acinar cells Total mean Ag
NOR count
2 ± 0.83* 1.2 ± 0.01* 1.6 ± 0.5
* Signiﬁcant difference, P= 0.01 (Mann–Whitney test).
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1996).
Some studies showed complete absence of HER-2/neu
expression in salivary gland tumors (Haltas et al., 2008; Ho-
vek-Gebeily et al., 2007), while others reported a high expres-
sion of HER-2/neu among salivary gland tumors (Shintani
et al., 1995; Ettl et al., 2008; Gaballah and Zedan, 2006).
The expression of HER-2/neu in normal salivary tissue of
the present study may be explained in two ways; the ﬁrst is that
the histologically normal salivary tissue surrounding salivary
tumors is undergoing tumorigenesis which may be supported
by the ﬁndings of previous researches in which normal salivary
tissue around tumors revealed expression of other types of
oncoproteins (Negri et al., 2008; Gaballah, in press).
The other explanation of HER-2/neu expression in normal
salivary tissue is that this protein has a role in the growth and
differentiation of normal salivary tissue which may be sup-
ported by the ﬁndings of other investigators, who reported ab-
sence of any prognostic signiﬁcance in salivary gland
carcinoma cases which expressed HER-2/neu. It was suggested
that HER-2/neu may play a role in cell differentiation in spe-
ciﬁc stages of development (Gompel et al., 1996; Haltas et al.,
2008; Ettl et al., 2008). However, the expression of HER-2/neu
in ductal cells of normal salivary tissue of the present study sig-
nals that these cells play an important role in histogenesis of
salivary gland tumors. A similar ﬁndings of ductal expression
of several types of oncoproteins in normal salivary tissue was
reported in other studies (Gaballah, in press; Kong et al.,
1998; Actis et al., 2002). Membranous and cytoplasmic expres-
sions of HER-2/neu protein were reported in other studies
(Gaballah and Zedan, 2006; Cho et al., 1999).
In this study mean Ag NOR counts in normal salivary tis-
sue of 1.6 ± 0.5 was similar to those of Behnam et al. (2006)
who reported 1.69 ± 0.19 mean number of Ag NORs in twelve
normal salivary gland tissue around salivary tumors. Also,
mean Ag NOR counts in normal salivary tissue of the present
study was similar to that found in chronic sialadenitis
(1.67 ± 0.14) and in some benign neoplasms (1.67 ± 0.11)
which was lower than that of malignant neoplasms
(3.59 ± 0.55) in the study of Adeyemi et al. (2006).
The mean number of Ag NORs in ductal cells among the
cases of the present study (2 ± 0.83) was similar to that reported
in the study of Vered and colleagues (Vered et al., 2004)
(2.2 ± 1.4). On the other hand, themeanAgNOR counts in aci-
nar cells of normal salivary tissue in their study (2.13 ± 1.1) was
nearly similar to that of ductal cells which contradicts the ﬁnding
of the present work as acinar cells of the normal salivary tissue
revealed a signiﬁcantly lower (P= 0.01) mean Ag NOR counts
(1.02 ± 0.01) than that reported for ductal cells. However,
Vered et al. (2004) reported a signiﬁcantly higher Ag NOR pro-
ﬁle area per nucleus for ductal cells (1.8 ± 0.5) than for acinar
cells of normal salivary tissue (1.2 ± 0.1).The role of ductal cells as a main source of salivary gland
tumors histogenesis which can be suggested from the ﬁndings
of the present study is further supported by similar ﬁndings
of studies investigating the histogenesis of different salivary
gland tumors, for example, in mucoepidermoid carcinoma
(Dardick et al., 1990; Soini et al., 2001), pleomorphic ade-
noma, Warthin’s tumor (Soini et al., 2001), adenoid cystic car-
cinoma (Chisholm et al., 1975), and acinic cell carcinoma
(Chaudhry et al., 1986).
The evident increased proliferative activity reported for
ductal cells as compared to acinar and other types of normal
salivary tissue cells in the present study may be explained by
the suggestion of Dayan and colleagues (2002) and of Vered
et al. (2004), as they stated that the different behaviour pattern
between the acinar and ductal cells probably derived from the
impact that the chronic inﬂammatory inﬁltrate might have
effect on the ductal epithelium located adjacent to it, the pres-
ence of chronic inﬂammation is closely associated with the
production of reactive oxygen species (ROS) and metabolites
within adjacent cells, with an ultimate result of inducing
DNA damage (Larsson et al., 2001) which is capable of induc-
ing activation of proto-oncogenes and/or impairment of tumor
suppressor genes in neighboring target cells (ductal cells) which
ultimately may pave the way for the development of salivary
tumors (Vered et al., 2004; Schwartsbard, 2003).
Although some investigators suggested that myoepithelial
cells have been speculated to play an important role in the his-
togenesis of some salivary gland tumors (Hubner et al., 1971;
Kazunovri, 2001; Bruce and Wertheimer, 1967; Soini et al.,
1999), others denied its role in salivary gland tumor histogen-
esis due to quite low proliferative activity (Batsakis et al., 1983;
Takabashi et al., 2001; Redman, 1994) which supports the
ﬁndings of the present study of absence of HER-2/neu expres-
sion or Ag NOR proteins in myoepithelial cells of normal sal-
ivary tissue cases in the present study.
The low proliferative activity of myoepithelial cells may be
explained by the ability of these cells to secrete substances
which inhibit proliferation, invasion and metastasis (e.g. pro-
teinase inhibitors like maspin and a-1-protease nexin II) which
contribute to anti-invasive matrix for myoepithelial rich sali-
vary gland tumors (Sternlicht et al., 1996). There is also some
evidence that myoepithelium might inhibit angiogenesis, fur-
ther contributing to local growth and inhibition of metastasis
(Sternlicht and Barsky, 1997; Zarbo, 2002).
Although many studies suggested that all salivary gland
cells may be capable of proliferation, including secretory aci-
nar cells (Maruya et al., 2004; Dayan et al., 2002; Shirasuna
et al., 2006; Miyazaki et al., 2002), the ﬁndings of the present
work presented ductal cells as the only highly proliferative
compartment in normal salivary tissue. Therefore, whether
one labels generative cells within salivary gland duct system
as pluripotential, stem, reserve, basal, transitional or undiffer-
entiated, they are considered as a regenerative pool and
oncogenic targets in normal salivary tissue which plays an
important role in the histogenesis of salivary gland tumors.
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